BioAge Labs Inc. (BIOA) vs Century Therapeutics, Inc. (IPSC)
A side-by-side comparison of BioAge Labs Inc. and Century Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIOA
BioAge Labs Inc.
$6.29HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
IPSC
Century Therapeutics, Inc.
$1.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BIOA vs IPSC
growth of $100 · dividends reinvested · last 2yBIOA -65.3% (-41.1%/yr)IPSC -3.3% (-1.6%/yr)IPSC compounded faster over this window
BIOA IPSC
BIOA vs IPSC: by the numbers
- •IPSC is the larger company ($239M vs $237M market cap).
- •Both run net losses; IPSC's is the smaller (-8.78% vs -912.25% net margin).
Metrics side by side
Valuation
| Metric | BIOA | IPSC |
|---|---|---|
| P/S ratio | 22.87 | N/A |
| P/B ratio | 0.63 | 1.03 |
Profitability
| Metric | BIOA | IPSC |
|---|---|---|
| Gross margin | 99.39% | 88.00% |
| Operating margin | -1026.28% | -13.78% |
| Net margin | -912.25% | -8.78% |
| ROE | -25.20% | -47.25% |
| ROIC | -28.14% | -43.69% |
Growth (annualized)
| Metric | BIOA | IPSC |
|---|---|---|
| Total return CAGR (5Y) | N/A | -42.05% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.